ID AA2BR_HUMAN Reviewed; 332 AA. AC P29275; DT 01-DEC-1992, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-1992, sequence version 1. DT 24-JAN-2024, entry version 199. DE RecName: Full=Adenosine receptor A2b; GN Name=ADORA2B; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX PubMed=1325798; DOI=10.1016/s0006-291x(05)81462-7; RA Pierce K.D., Furlong T.J., Selbie L.A., Shine J.; RT "Molecular cloning and expression of an adenosine A2b receptor from human RT brain."; RL Biochem. Biophys. Res. Commun. 187:86-93(1992). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX PubMed=7558011; DOI=10.1006/geno.1995.1061; RA Jacobson M.A., Johnson R.G., Luneau C.J., Salvatore C.A.; RT "Cloning and chromosomal localization of the human A2b adenosine receptor RT gene (ADORA2B) and its pseudogene."; RL Genomics 27:374-376(1995). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RA Puhl H.L. III, Ikeda S.R., Aronstam R.S.; RT "cDNA clones of human proteins involved in signal transduction sequenced by RT the Guthrie cDNA resource center (www.cdna.org)."; RL Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Receptor for adenosine. The activity of this receptor is CC mediated by G proteins which activate adenylyl cyclase. CC -!- INTERACTION: CC P29275; P29274: ADORA2A; NbExp=5; IntAct=EBI-3904751, EBI-2902702; CC -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M97759; AAA51598.1; -; mRNA. DR EMBL; X68487; CAA48505.1; -; mRNA. DR EMBL; AY136748; AAN01274.1; -; mRNA. DR EMBL; BC025722; AAH25722.1; -; mRNA. DR CCDS; CCDS11173.1; -. DR PIR; JC1229; JC1229. DR RefSeq; NP_000667.1; NM_000676.2. DR PDB; 7XY6; EM; 2.99 A; R=2-332. DR PDB; 7XY7; EM; 3.26 A; R=2-332. DR PDB; 8HDO; EM; 2.87 A; R=1-332. DR PDB; 8HDP; EM; 3.20 A; R=1-332. DR PDBsum; 7XY6; -. DR PDBsum; 7XY7; -. DR PDBsum; 8HDO; -. DR PDBsum; 8HDP; -. DR AlphaFoldDB; P29275; -. DR EMDB; EMD-34676; -. DR EMDB; EMD-34677; -. DR SMR; P29275; -. DR BioGRID; 106648; 46. DR IntAct; P29275; 3. DR STRING; 9606.ENSP00000304501; -. DR BindingDB; P29275; -. DR ChEMBL; CHEMBL255; -. DR DrugBank; DB00640; Adenosine. DR DrugBank; DB00201; Caffeine. DR DrugBank; DB05936; CVT-6883. DR DrugBank; DB04932; Defibrotide. DR DrugBank; DB00824; Enprofylline. DR DrugBank; DB00277; Theophylline. DR DrugCentral; P29275; -. DR GuidetoPHARMACOLOGY; 20; -. DR GlyCosmos; P29275; 2 sites, No reported glycans. DR GlyGen; P29275; 2 sites. DR iPTMnet; P29275; -. DR PhosphoSitePlus; P29275; -. DR BioMuta; ADORA2B; -. DR DMDM; 112938; -. DR MassIVE; P29275; -. DR PaxDb; 9606-ENSP00000304501; -. DR PeptideAtlas; P29275; -. DR Antibodypedia; 25203; 393 antibodies from 37 providers. DR DNASU; 136; -. DR Ensembl; ENST00000304222.3; ENSP00000304501.2; ENSG00000170425.4. DR GeneID; 136; -. DR KEGG; hsa:136; -. DR MANE-Select; ENST00000304222.3; ENSP00000304501.2; NM_000676.4; NP_000667.1. DR UCSC; uc002gpd.2; human. DR AGR; HGNC:264; -. DR CTD; 136; -. DR DisGeNET; 136; -. DR GeneCards; ADORA2B; -. DR HGNC; HGNC:264; ADORA2B. DR HPA; ENSG00000170425; Tissue enhanced (urinary). DR MIM; 600446; gene. DR neXtProt; NX_P29275; -. DR OpenTargets; ENSG00000170425; -. DR PharmGKB; PA24585; -. DR VEuPathDB; HostDB:ENSG00000170425; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT01030000234555; -. DR HOGENOM; CLU_009579_11_5_1; -. DR InParanoid; P29275; -. DR OMA; CRREELY; -. DR OrthoDB; 2909020at2759; -. DR PhylomeDB; P29275; -. DR TreeFam; TF325296; -. DR PathwayCommons; P29275; -. DR Reactome; R-HSA-417973; Adenosine P1 receptors. DR Reactome; R-HSA-418555; G alpha (s) signalling events. DR Reactome; R-HSA-5683826; Surfactant metabolism. DR Reactome; R-HSA-9660821; ADORA2B mediated anti-inflammatory cytokines production. DR SignaLink; P29275; -. DR SIGNOR; P29275; -. DR BioGRID-ORCS; 136; 6 hits in 1160 CRISPR screens. DR ChiTaRS; ADORA2B; human. DR GeneWiki; Adenosine_A2B_receptor; -. DR GenomeRNAi; 136; -. DR Pharos; P29275; Tclin. DR PRO; PR:P29275; -. DR Proteomes; UP000005640; Chromosome 17. DR RNAct; P29275; Protein. DR Bgee; ENSG00000170425; Expressed in mucosa of transverse colon and 132 other cell types or tissues. DR GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0098793; C:presynapse; IEA:GOC. DR GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IEA:Ensembl. DR GO; GO:0001609; F:G protein-coupled adenosine receptor activity; IEA:InterPro. DR GO; GO:0004930; F:G protein-coupled receptor activity; IBA:GO_Central. DR GO; GO:0007190; P:activation of adenylate cyclase activity; TAS:ProtInc. DR GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central. DR GO; GO:0031668; P:cellular response to extracellular stimulus; IEA:Ensembl. DR GO; GO:0019934; P:cGMP-mediated signaling; IEA:Ensembl. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; TAS:ProtInc. DR GO; GO:0043303; P:mast cell degranulation; IEA:Ensembl. DR GO; GO:0010753; P:positive regulation of cGMP-mediated signaling; IEA:Ensembl. DR GO; GO:0032722; P:positive regulation of chemokine production; IEA:Ensembl. DR GO; GO:0002882; P:positive regulation of chronic inflammatory response to non-antigenic stimulus; IEA:Ensembl. DR GO; GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl. DR GO; GO:0043306; P:positive regulation of mast cell degranulation; IEA:Ensembl. DR GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; IEA:Ensembl. DR GO; GO:0099171; P:presynaptic modulation of chemical synaptic transmission; IEA:Ensembl. DR GO; GO:0060087; P:relaxation of vascular associated smooth muscle; IEA:Ensembl. DR GO; GO:0042311; P:vasodilation; IBA:GO_Central. DR CDD; cd15069; 7tmA_Adenosine_R_A2B; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR001435; Adeno_A2B_rcpt. DR InterPro; IPR001634; Adenosn_rcpt. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR PANTHER; PTHR24246:SF18; ADENOSINE RECEPTOR A2B; 1. DR PANTHER; PTHR24246; OLFACTORY RECEPTOR AND ADENOSINE RECEPTOR; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00554; ADENOSINA2BR. DR PRINTS; PR00424; ADENOSINER. DR PRINTS; PR00237; GPCRRHODOPSN. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P29275; HS. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Disulfide bond; G-protein coupled receptor; KW Glycoprotein; Lipoprotein; Membrane; Palmitate; Receptor; KW Reference proteome; Transducer; Transmembrane; Transmembrane helix. FT CHAIN 1..332 FT /note="Adenosine receptor A2b" FT /id="PRO_0000069003" FT TOPO_DOM 1..8 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 9..33 FT /note="Helical; Name=1" FT /evidence="ECO:0000250" FT TOPO_DOM 34..43 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 44..67 FT /note="Helical; Name=2" FT /evidence="ECO:0000250" FT TOPO_DOM 68..78 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 79..101 FT /note="Helical; Name=3" FT /evidence="ECO:0000250" FT TOPO_DOM 102..121 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 122..144 FT /note="Helical; Name=4" FT /evidence="ECO:0000250" FT TOPO_DOM 145..178 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 179..203 FT /note="Helical; Name=5" FT /evidence="ECO:0000250" FT TOPO_DOM 204..235 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 236..259 FT /note="Helical; Name=6" FT /evidence="ECO:0000250" FT TOPO_DOM 260..267 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 268..291 FT /note="Helical; Name=7" FT /evidence="ECO:0000250" FT TOPO_DOM 292..332 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT BINDING 174 FT /ligand="adenosine" FT /ligand_id="ChEBI:CHEBI:16335" FT /ligand_note="agonist" FT /evidence="ECO:0000250|UniProtKB:P29274" FT BINDING 254 FT /ligand="adenosine" FT /ligand_id="ChEBI:CHEBI:16335" FT /ligand_note="agonist" FT /evidence="ECO:0000250|UniProtKB:P29274" FT BINDING 279 FT /ligand="adenosine" FT /ligand_id="ChEBI:CHEBI:16335" FT /ligand_note="agonist" FT /evidence="ECO:0000250|UniProtKB:P29274" FT BINDING 280 FT /ligand="adenosine" FT /ligand_id="ChEBI:CHEBI:16335" FT /ligand_note="agonist" FT /evidence="ECO:0000250|UniProtKB:P29274" FT LIPID 311 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000255" FT CARBOHYD 153 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 163 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 78..171 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT HELIX 5..33 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 41..69 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 75..108 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 113..116 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 119..137 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 140..142 FT /evidence="ECO:0007829|PDB:7XY6" FT TURN 147..149 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 173..175 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 179..184 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 186..190 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 192..217 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 224..259 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 262..265 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 270..290 FT /evidence="ECO:0007829|PDB:7XY6" FT TURN 291..293 FT /evidence="ECO:0007829|PDB:7XY6" FT HELIX 295..307 FT /evidence="ECO:0007829|PDB:7XY6" SQ SEQUENCE 332 AA; 36333 MW; 38AD088E2439C7FA CRC64; MLLETQDALY VALELVIAAL SVAGNVLVCA AVGTANTLQT PTNYFLVSLA AADVAVGLFA IPFAITISLG FCTDFYGCLF LACFVLVLTQ SSIFSLLAVA VDRYLAICVP LRYKSLVTGT RARGVIAVLW VLAFGIGLTP FLGWNSKDSA TNNCTEPWDG TTNESCCLVK CLFENVVPMS YMVYFNFFGC VLPPLLIMLV IYIKIFLVAC RQLQRTELMD HSRTTLQREI HAAKSLAMIV GIFALCWLPV HAVNCVTLFQ PAQGKNKPKW AMNMAILLSH ANSVVNPIVY AYRNRDFRYT FHKIISRYLL CQADVKSGNG QAGVQPALGV GL //